120 related articles for article (PubMed ID: 3046878)
1. Sulfonylurea-induced decrease of muscle capillary basement membrane thickness in diabetes.
Camerini-Davalos RA; Velasco CA; Glasser M; Bloodworth JM
Diabetes Res Clin Pract; 1988 Jul; 5(2):113-23. PubMed ID: 3046878
[TBL] [Abstract][Full Text] [Related]
2. Delay of progression of diabetic microangiopathy.
Camerini-Davalos RA; Velasco CA; Reddi AS; Glasser M; Bloodworth JM
Metabolism; 1988 Feb; 37(2 Suppl 1):10-8. PubMed ID: 2963192
[TBL] [Abstract][Full Text] [Related]
3. Effect of insulin-glipizide combination on skeletal muscle capillary basement membrane width in diabetic patients.
Camerini-Davalos RA; Bloodworth JM; Velasco CA; Reddi AS
Clin Ther; 1994; 16(6):952-61. PubMed ID: 7697692
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced reversal of early diabetic microangiopathy.
Camerini-Davalos RA; Velasco C; Glasser M; Bloodworth JM
N Engl J Med; 1983 Dec; 309(25):1551-6. PubMed ID: 6656850
[TBL] [Abstract][Full Text] [Related]
5. Muscle capillary basement membrane width in patients with vacor-induced diabetes mellitus.
Feingold KR; Lee TH; Chung MY; Siperstein MD
J Clin Invest; 1986 Jul; 78(1):102-7. PubMed ID: 3722372
[TBL] [Abstract][Full Text] [Related]
6. The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with Type I diabetes mellitus.
Raskin P; Pietri AO; Unger R; Shannon WA
N Engl J Med; 1983 Dec; 309(25):1546-50. PubMed ID: 6361554
[TBL] [Abstract][Full Text] [Related]
7. Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus.
Rosenstock J; Meisel A; Raskin P
Am J Med; 1987 Sep; 83(3A):10-5. PubMed ID: 3307402
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term insulin therapy upon therapeutic response to glipizide.
Schwartz SL; Fischer JS; Kipnes MS; Boyle M
Am J Med; 1987 Sep; 83(3A):22-30. PubMed ID: 3307403
[TBL] [Abstract][Full Text] [Related]
9. Effect of glycemic control on microvascular complications in patients with type I diabetes mellitus.
Rosenstock J; Friberg T; Raskin P
Am J Med; 1986 Dec; 81(6):1012-8. PubMed ID: 3541587
[TBL] [Abstract][Full Text] [Related]
10. [Long-term effects of glipizide at the pancreatic and extra-pancreatic level in non-insulin dependent diabetics].
Sánchez MS; Ordóñez AJ; Villalba MT; de la Viña S; Nash RE; Serrano M
Rev Med Chil; 1984 Feb; 112(2):107-14. PubMed ID: 6377432
[No Abstract] [Full Text] [Related]
11. Relationship of muscle capillary basement membrane to renal structure and function in diabetes mellitus.
Ellis EN; Mauer SM; Goetz FC; Sutherland DE; Steffes MW
Diabetes; 1986 Apr; 35(4):421-5. PubMed ID: 3956879
[TBL] [Abstract][Full Text] [Related]
12. The effect of aldose reductase inhibition with ponalrestat on the width of the capillary basement membrane in diabetes mellitus.
Ramirez LC; Arauz C; Pruneda L; Hammon K; Rosenstock J; Raskin P
Diabetes Res Clin Pract; 1991 Feb; 11(2):73-80. PubMed ID: 1902410
[TBL] [Abstract][Full Text] [Related]
13. Combination of two sulfonylureas. Does it make sense.
Salo S; Groop L
Diabetes Care; 1988 Oct; 11(9):751-3. PubMed ID: 3147175
[No Abstract] [Full Text] [Related]
14. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
Simpson HC; Sturley R; Stirling CA; Reckless JP
Diabet Med; 1990 Feb; 7(2):143-7. PubMed ID: 2137755
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of first-generation sulfonylureas and glipizide in non-insulin-dependent diabetes mellitus.
Beisswenger PJ; Dias N; Beckman F
Am J Med; 1987 Sep; 83(3A):16-21. PubMed ID: 3631118
[TBL] [Abstract][Full Text] [Related]
16. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
Lev JD; Zeidler A; Kumar D
Diabetes Care; 1987; 10(6):679-82. PubMed ID: 3123183
[TBL] [Abstract][Full Text] [Related]
17. Improved diabetes control reduces skeletal muscle capillary basement membrane width in insulin-dependent diabetes mellitus.
Rosenstock J; Challis P; Strowig S; Raskin P
Diabetes Res Clin Pract; 1988 Feb; 4(3):167-75. PubMed ID: 3359916
[TBL] [Abstract][Full Text] [Related]
18. Kidney disease in KK mice: effect of glipizide.
Reddi AS; Velasco CA; Khan MY; Bloodworth JM; Camerini-Davalos RA
Adv Exp Med Biol; 1988; 246():305-12. PubMed ID: 3250259
[No Abstract] [Full Text] [Related]
19. Prospective studies of muscle capillary basement membrane width in prediabetics.
Feingold KR; Browner WS; Siperstein MD
J Clin Endocrinol Metab; 1989 Oct; 69(4):784-9. PubMed ID: 2778035
[TBL] [Abstract][Full Text] [Related]
20. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
Goldstein BJ; Pans M; Rubin CJ
Clin Ther; 2003 Mar; 25(3):890-903. PubMed ID: 12852706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
